Hydroxychloroquine Linked to Less Heart Risk in Lupus

Angie Davidson

12 January 2022

Canada

Hydroxychloroquine Linked to Less Heart Risk in Lupus

Current use of hydroxychloroquine was associated with a significantly decreased risk for cardiovascular events among patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE),

Angie Davidson

6 April 2021

USA

HCQ associated with lower platelet activity and improved vascular health

Angie Davidson

6 April 2021

USA

HCQ associated with lower platelet activity and improved vascular health

Hydroxychloroquine (HCQ) treatment may reduce platelet aggregation (clumping together of platelets in the blood) and improve vascular health in patients with systemic lupus erythematosus (SLE), according to study results published in Lupus Science & Medicine.

THE CONTENT ON THIS WEBSITE SHOULD NOT BE SEEN AS SUBSTITUTE FOR MEDICAL ADVICE. IF YOU HAVE, OR THINK YOU MAY HAVE, LUPUS, ALWAYS SEEK ADVICE FROM A QUALIFIED PHYSICIAN. FIND OUT MORE IN OUR TERMS OF USE.